Actively Recruiting
Adherence to and Understanding of a Therapeutic Education Program for Patients With Central Venous Lines
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2024-10-18
100
Participants Needed
1
Research Sites
6 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating a therapeutic education program designed for patients with central venous lines such as PICC lines, focusing on how well patients adhere to the program and understand its messages. The study aims to empower patients in managing their own care to reduce risks like infections or complications related to these invasive devices. This research is part of a collaborative effort that includes developing a mobile application for education and monitoring, supported by national healthcare structures to improve risk management between hospital and community care. Participants will be involved in a prospective observational study where their knowledge and adherence to communication tools are assessed. The program includes questionnaires and webinars as educational interventions. The study will specifically evaluate patients' understanding and adherence six weeks after inclusion, and also identify demographic, pathology-related, and management-related factors that could influence outcomes. Participants will communicate through internet-connected devices or alternative means and will be monitored for their understanding and adherence to the educational content. The primary outcome is the level of understanding at six weeks post-inclusion, with secondary outcomes including adherence and individual factors. The study spans at least six weeks, with data collected through questionnaires and webinars. Participants' safety and comprehension are closely monitored during this period to support effective therapeutic education.
CONDITIONS
Brief Title
Adherence and Understanding of a Therapeutic Education Program for Patients With Central Venous Access (EDUVVC)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients over 18 years of age
- Patients requiring a PICC line
- Patients with a way to communicate via internet-connected computer, cell phone, or landline phone
- Patients with a predicted life expectancy longer than 6 weeks
You will not qualify if you...
- Patients who do not want to participate in the study
- Patients who do not understand French
- Patients not covered by a French social security scheme
- Patients under legal guardianship or curatorship
- Patients under court protection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Duration - 6 weeks post inclusion
Participants complete questionnaires and webinars to evaluate their understanding and adherence to the therapeutic education program for central venous lines.
Periodic remote assessments over 6 weeks
Trial Site Locations
Total: 1 location
1
Hopital Avicenne
Bobigny, France, 93000
Actively Recruiting
Research Team
C
Camille REINPRECHT
Z
Zahar Jean Ralph, PUPH
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here